Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -3.36%6.35B | 6.00%6.45B | -2.12%5.68B | 5.12%24.45B | -2.92%5.99B | 7.49%6.57B | 4.12%6.09B | 13.10%5.8B | 8.90%23.26B | 11.52%6.17B |
Cost of revenue | -5.27%4.44B | 6.22%4.61B | 0.55%4.17B | 7.10%17.61B | -0.07%4.43B | 8.84%4.69B | 6.53%4.34B | 14.42%4.15B | 6.82%16.44B | 10.83%4.43B |
Gross profit | 1.43%1.91B | 5.44%1.84B | -8.90%1.5B | 0.34%6.84B | -10.25%1.56B | 4.21%1.88B | -1.36%1.75B | 9.92%1.65B | 14.25%6.82B | 13.32%1.74B |
Operating expense | -8.26%533M | 0.35%570M | -12.91%526M | -14.05%2.26B | -17.61%510M | -17.24%581M | -16.84%568M | -3.97%604M | 2.05%2.63B | -9.90%619M |
Staff costs | ---- | ---- | ---- | -10.28%672M | ---- | ---- | ---- | ---- | 4.90%749M | ---- |
Selling and administrative expenses | ---- | ---- | ---- | -27.47%528M | ---- | ---- | ---- | ---- | 10.30%728M | ---- |
-Selling and marketing expense | ---- | ---- | ---- | -8.57%32M | ---- | ---- | ---- | ---- | -14.63%35M | ---- |
-General and administrative expense | ---- | ---- | ---- | -28.43%496M | ---- | ---- | ---- | ---- | 11.95%693M | ---- |
Research and development costs | ---- | ---- | ---- | -10.57%406M | ---- | ---- | ---- | ---- | -10.10%454M | ---- |
Depreciation and amortization | ---- | ---- | ---- | 4.24%123M | ---- | ---- | ---- | ---- | -10.61%118M | ---- |
-Depreciation | ---- | ---- | ---- | 4.24%123M | ---- | ---- | ---- | ---- | -10.61%118M | ---- |
Other operating expenses | ---- | ---- | ---- | -8.56%534M | ---- | ---- | ---- | ---- | 2.64%584M | ---- |
Operating profit | 5.76%1.38B | 7.89%1.27B | -6.59%978M | 9.40%4.58B | -6.18%1.05B | 17.83%1.3B | 8.36%1.18B | 19.93%1.05B | 23.54%4.18B | 32.19%1.12B |
Net non-operating interest income (expenses) | -23.16%73M | 5.74%129M | -3.30%88M | 31.31%411M | 27.16%103M | 1.06%95M | 56.41%122M | 51.67%91M | 26.21%313M | 17.39%81M |
Non-operating interest income | -23.16%73M | 5.74%129M | -3.30%88M | 31.31%411M | 27.16%103M | 1.06%95M | 56.41%122M | 51.67%91M | 26.21%313M | 17.39%81M |
Net investment income | -479.76%-319M | -14.29%216M | 1,445.45%148M | -37.84%207M | 52.23%-118M | -61.64%84M | -6.67%252M | -112.09%-11M | 48.66%333M | -648.89%-247M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 5,700.00%58M | -200.00%-1M | 0 | -101.47%-43M | 61.95%-86M | -99.92%1M | -99.94%1M | -80.75%41M | 20,950.00%2.92B | -1,954.55%-226M |
Less:Other special charges | -5,700.00%-58M | ---- | ---- | 101.40%43M | -61.95%86M | 99.92%-1M | 99.95%-1M | 80.75%-41M | -22,064.29%-3.08B | 1,954.55%226M |
Less:Write off | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --156M | --0 |
Other non-operating income (expenses) | -22.73%17M | -8.33%22M | -52.17%22M | -0.83%120M | 16.67%28M | 4.76%22M | -52.94%24M | 84.00%46M | 42.35%121M | 33.33%24M |
Income before tax | -19.75%1.21B | 3.54%1.64B | 2.06%1.24B | -32.98%5.27B | 30.47%972M | -43.05%1.5B | -50.82%1.58B | -3.88%1.21B | 100.38%7.86B | -22.48%745M |
Income tax | -18.81%354M | -19.76%463M | 70.32%373M | -45.52%1.5B | -60.68%265M | -42.40%436M | -41.66%577M | -33.23%219M | 185.65%2.75B | 217.92%674M |
Net income | -20.04%854M | 16.93%1.17B | -13.08%864M | -26.26%3.77B | 880.56%706M | -43.28%1.07B | -54.92%1B | 6.54%994M | 72.69%5.12B | -90.39%72M |
Net income continuous operations | -20.13%853M | 16.93%1.17B | -12.98%865M | -26.24%3.77B | 895.77%707M | -43.31%1.07B | -54.90%1B | 6.42%994M | 72.69%5.12B | -90.52%71M |
Noncontrolling interests | 63.64%36M | -33.33%16M | -116.67%-2M | -14.13%79M | -12.50%21M | -64.52%22M | 1,300.00%24M | 50.00%12M | -36.55%92M | -17.24%24M |
Net income attributable to the company | -21.80%818M | 18.06%1.16B | -11.62%867M | -26.46%3.69B | 1,359.57%686M | -42.59%1.05B | -56.01%980M | 6.05%981M | 78.27%5.02B | -93.48%47M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -21.80%818M | 18.06%1.16B | -11.62%867M | -26.46%3.69B | 1,359.57%686M | -42.59%1.05B | -56.01%980M | 6.05%981M | 78.27%5.02B | -93.48%47M |
Gross dividend payment | ||||||||||
Basic earnings per share | -18.58%36.12 | 19.85%49.76 | -11.61%36.78 | -24.00%156.55 | 730.29%29.06 | -40.77%44.36 | -54.14%41.52 | 12.25%41.61 | 86.17%206 | -87.78%3.5 |
Diluted earnings per share | -18.53%36.12 | 19.85%49.76 | -11.61%36.78 | -24.00%156.55 | 1,359.51%29.06 | -40.80%44.3372 | -54.14%41.52 | 12.25%41.61 | 86.17%206 | -93.05%1.9911 |
Dividend per share | 0 | 0 | 0 | 100.00%100 | 100.00%100 | 0 | 0 | 0 | 0.00%50 | 0.00%50 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |